Summary: NLS Pharmaceutics Ltd announced the publication of a new patent application by Aexon Labs with the World Intellectual Property Organization, introducing a novel series of dual orexin receptor agonists. These compounds are designed to treat narcolepsy and … [Read more...]
Fullpower-AI Secures New Patents to Enhance Sleep with AI
Summary: Fullpower-AI has secured 5 new patents from the US Patent and Trademark Business, boosting its portfolio in sleep and wellness innovation. The patents focus on various technologies which includes a sounds-resilient snooze details assortment program, a non-get hold of … [Read more...]
Harmony Secures Rights to Develop Bioprojet’s Orexin-2 Agonist
Summary: Harmony Biosciences has secured an unique license from Bioprojet to establish, manufacture, and commercialize TPM-1116, an oral orexin-2 receptor agonist, in the United States and Latin The united states. This drug, aimed at dealing with narcolepsy and other rest … [Read more...]
NLS Secures Exclusive License for Dual Orexin Agonist Platform
Swiss biopharmaceutical enterprise NLS Pharmaceutics Ltd declared an exclusive worldwide license arrangement with Aexon Labs Inc, a US-centered biotech agency, to purchase global advancement and commercialization legal rights to Aexon’s twin orexin receptor agonists system. These … [Read more...]